Neovacs

Region Europa
ISIN FR0004032746
Sektor Biotechnologie
Website http://neovacs.fr/

Neovacs ist ein französisches Biotech-Unternehmen mit Schwerpunkt auf der Entwicklung von Kinoids, therapeutischen Impfstoffen zur Behandlung von Autoimmun-, Entzündungskrankheiten, Allergien und Krebs.


News

Titel Datum
NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF ITS PROOF OF CONCEPT IN ALLERGIES WITH IL-4 / IL-13 KINOID HAVE TRIGGERED THE FIRST PAYMEN...
· PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THAT THE POSITIVE RESULTS OF I...
vor 9 Tagen
NEOVACS ANNOUNCES THE APPOINTMENT of Dr. VIRGINIA PASCUAL AS MEDICAL AND SCIENTIFIC ADVISOR
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE APPOINTMENT ofDr. VIRGINIA P...
vor 21 Tagen
NEOVACS: Neovacs to present the pre-clinical results of its IFNalpha Kinoid to treat type 1 diabetes - American Diabetes Association's 79...
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS...
vor ungefähr einem Monat
NEOVACS: Neovacs to present the pre-clinical results of its therapeutic vaccine candidate IL-4 / IL-13 Kinoid to treat allergic Asthma
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT THE PRE-CLINICAL RESULTS OF ITS...
vor ungefähr 2 Monaten
NEOVACS: Neovacs announces the full results of its Phase IIb Clinical study of IFNalpha Kinoid in lupus - 13th International Lupus Congre...
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES THE FULL RESULTS OF ITSPHASE IIb...
vor ungefähr 3 Monaten